{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:00:44Z","timestamp":1784905244844,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-026-01193-4","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:15:17Z","timestamp":1782814517000},"page":"1149-1157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study"],"prefix":"10.1038","volume":"7","author":[{"given":"Ya-Lan","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Fen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-9785","authenticated-orcid":false,"given":"Xi-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Fang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7605-3609","authenticated-orcid":false,"given":"Wen-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7989-4224","authenticated-orcid":false,"given":"Guan-Qun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9278-0929","authenticated-orcid":false,"given":"Jia-Wei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Xia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-1454","authenticated-orcid":false,"given":"Ling-Long","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Yun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4827-5524","authenticated-orcid":false,"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-2929","authenticated-orcid":false,"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-9349","authenticated-orcid":false,"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1027-071X","authenticated-orcid":false,"given":"Yan-Ping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0010-3494","authenticated-orcid":false,"given":"Yu-Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen, Y. P. et al. Nasopharyngeal carcinoma. Lancet 394, 64\u201380 (2019).","journal-title":"Lancet"},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ijc.32099","volume":"145","author":"WF Li","year":"2019","unstructured":"Li, W. F. et al. Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: long-term results of phase 3 randomized controlled trial. Int. J. Cancer 145, 295\u2013305 (2019).","journal-title":"Int. J. Cancer"},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s44178-025-00181-5","volume":"4","author":"L-T Liu","year":"2025","unstructured":"Liu, L.-T. et al. CACA guidelines for holistic integrative management of adolescent and childhood nasopharyngeal carcinoma. Holist. Integr. Oncol. 4, 46 (2025).","journal-title":"Holist. Integr. Oncol."},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejca.2017.01.002","volume":"75","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase 3 multicentre randomised controlled trial. Eur. J. Cancer 75, 150\u2013158 (2017).","journal-title":"Eur. J. Cancer"},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2018.77.7847","volume":"36","author":"ATC Chan","year":"2018","unstructured":"Chan, A. T. C. et al. Analysis of plasma Epstein-Barr virus DNA in nasopharyngeal cancer after chemoradiation to identify high-risk patients for adjuvant chemotherapy: a randomized controlled trial. J. Clin. Oncol. 36, 3091\u20133100 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.3390\/cancers15092471","volume":"15","author":"E Muraro","year":"2023","unstructured":"Muraro, E. et al. Metronomic chemotherapy: anti-tumor pathways and combination with immune checkpoint inhibitors. Cancers 15, 2471 (2023).","journal-title":"Cancers"},{"key":"1193_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(21)01123-5","volume":"398","author":"YP Chen","year":"2021","unstructured":"Chen, Y. P. et al. Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet 398, 303\u2013313 (2021).","journal-title":"Lancet"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"e1609","DOI":"10.1002\/onco.13822","volume":"26","author":"CM Nielson","year":"2021","unstructured":"Nielson, C. M., Bylsma, L. C., Fryzek, J. P., Saad, H. A. & Crawford, J. Relative dose intensity of chemotherapy and survival in patients with advanced stage solid tumor cancer: a systematic review and meta-analysis. Oncologist 26, e1609\u2013e1618 (2021).","journal-title":"Oncologist"},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"e082440","DOI":"10.1136\/bmj-2024-082440","volume":"390","author":"P Lopez-Ayala","year":"2025","unstructured":"Lopez-Ayala, P., Riley, R. D., Collins, G. S. & Zimmermann, T. Dealing with continuous variables and modelling non-linear associations in healthcare data: practical guide. Brit. Med. J. 390, e082440 (2025).","journal-title":"Brit. Med. J."},{"key":"1193_CR10","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/biom13121803","volume":"13","author":"M Mosca","year":"2023","unstructured":"Mosca, M., Nigro, M. C., Pagani, R., De Giglio, A. & Di Federico, A. Neutrophil-to-lymphocyte ratio (NLR) in NSCLC, gastrointestinal, and other solid tumors: immunotherapy and beyond. Biomolecules 13, 1803 (2023).","journal-title":"Biomolecules"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.3390\/ijms23073636","volume":"23","author":"A Buonacera","year":"2022","unstructured":"Buonacera, A., Stancanelli, B., Colaci, M. & Malatino, L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int. J. Mol. Sci. 23, 3636 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1193_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24670","volume":"10","author":"N Jan","year":"2024","unstructured":"Jan, N. et al. Metronomic chemotherapy and drug repurposing: a paradigm shift in oncology. Heliyon 10, e24670 (2024).","journal-title":"Heliyon"},{"key":"1193_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17672-w","volume":"11","author":"GQ Zhou","year":"2020","unstructured":"Zhou, G. Q. et al. An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach. Nat. Commun. 11, 3872 (2020).","journal-title":"Nat. Commun."},{"key":"1193_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2016.12.018","volume":"400","author":"E Biziota","year":"2017","unstructured":"Biziota, E., Mavroeidis, L., Hatzimichael, E. & Pappas, P. Metronomic chemotherapy: a potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activation. Cancer Lett. 400, 243\u2013251 (2017).","journal-title":"Cancer Lett."},{"key":"1193_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","volume":"16","author":"ME Shaul","year":"2019","unstructured":"Shaul, M. E. & Fridlender, Z. G. Tumour-associated neutrophils in patients with cancer. Nat. Rev. Clin. Oncol. 16, 601\u2013620 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1038\/s41591-024-03088-2","volume":"30","author":"H Mo","year":"2024","unstructured":"Mo, H. et al. Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial. Nat. Med. 30, 2528\u20132539 (2024).","journal-title":"Nat. Med."},{"key":"1193_CR17","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1158\/0008-5472.CAN-25-3669","volume":"86","author":"Z Deng","year":"2026","unstructured":"Deng, Z. et al. Metronomic chemotherapy induces metabolic reprogramming in cancer cells that modulates mature regulatory dendritic cell function to stimulate antitumor immunity. Cancer Res. 86, 2793\u20132809 (2026).","journal-title":"Cancer Res."},{"key":"1193_CR18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2025.1132","volume":"333","author":"YL Liang","year":"2025","unstructured":"Liang, Y. L. et al. Adjuvant PD-1 blockade with camrelizumab for nasopharyngeal carcinoma: the DIPPER Randomized Clinical Trial. JAMA 333, 1589\u20131598 (2025).","journal-title":"JAMA"},{"key":"1193_CR19","doi-asserted-by":"publisher","first-page":"e081123","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell, S. et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. Brit. Med. J. 389, e081123 (2025).","journal-title":"Brit. Med. J."},{"key":"1193_CR20","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/S0140-6736(02)08594-X","volume":"359","author":"SJ Pocock","year":"2002","unstructured":"Pocock, S. J., Clayton, T. C. & Altman, D. G. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 359, 1686\u20131689 (2002).","journal-title":"Lancet"},{"key":"1193_CR21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/biostatistics\/kxs043","volume":"14","author":"EP Wileyto","year":"2013","unstructured":"Wileyto, E. P., Li, Y., Chen, J. & Heitjan, D. F. Assessing the fit of parametric cure models. Biostatistics 14, 340\u2013350 (2013).","journal-title":"Biostatistics"},{"key":"1193_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jclinepi.2010.11.016","volume":"64","author":"DJ Fisher","year":"2011","unstructured":"Fisher, D. J., Copas, A. J., Tierney, J. F. & Parmar, M. K. A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. J. Clin. Epidemiol. 64, 949\u2013967 (2011).","journal-title":"J. Clin. Epidemiol."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01193-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01193-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01193-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:01:44Z","timestamp":1784901704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01193-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1038\/s43018-026-01193-4","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}